Adjuvant and neoadjuvant therapies in high risk localized prostate cancer

dc.contributor.authorGiannakopoulos, X.en
dc.contributor.authorStagikas, D.en
dc.contributor.authorCharalabopoulos, A.en
dc.contributor.authorSofikitis, N.en
dc.contributor.authorCharalabopoulos, K.en
dc.date.accessioned2015-11-24T19:37:31Z
dc.date.available2015-11-24T19:37:31Z
dc.identifier.issn0392-9078-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24043
dc.rightsDefault Licence-
dc.subjectAndrogen Antagonists/therapeutic useen
dc.subjectChemotherapy, Adjuvanten
dc.subjectHumansen
dc.subjectMaleen
dc.subjectNeoadjuvant Therapyen
dc.subjectProstatic Neoplasms/drug therapy/pathology/surgery/*therapyen
dc.subjectRadiotherapy, Adjuvanten
dc.titleAdjuvant and neoadjuvant therapies in high risk localized prostate canceren
heal.abstractIn this review article adjuvant and neoadjuvant therapies in patients at high risk for localized prostate cancer are presented in some detail. Adjuvant hormone therapy by antiandrogens as well as antineoplastic chemotherapeutic agents such as estramustine and taxanes are referred. Neoadjuvant therapies in addition to systemic therapy before or after local treatment for prostate cancer may improve the outcome of high risk patients otherwise destined to treatment fail. Data regarding some substances used in neoadjuvant therapies such as androgen deprivation therapy and use of rapamycin with its analogs, as well as some novel therapeutic approach strategies are also discussed.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17310835-
heal.journalNameJ Exp Clin Cancer Resen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: